We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
-4.88%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$217M
AUM Growth
+$14.7M
(+7.3%)
Cap. Flow
-$10.7M
Cap. Flow
% of AUM
-4.92%
Top 10 Holdings %
Top 10 Hldgs %
31.84%
Holding
169
New
34
Increased
48
Reduced
19
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TGAN
Transphorm, Inc. Common Stock
TGAN
|
+$4.28M |
| 2 |
Essex Property Trust
ESS
|
+$4.25M |
| 3 |
CAMP
CalAmp Corp.
CAMP
|
+$2.92M |
| 4 |
Evolus
EOLS
|
+$1.72M |
| 5 |
DZSI
DZS Inc. Common Stock
DZSI
|
+$1.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lantronix
LTRX
|
+$1.24M |
| 2 |
Mirum Pharmaceuticals
MIRM
|
+$1.24M |
| 3 |
OIIM
02Micro International
OIIM
|
+$1.11M |
| 4 |
FOCL
EDAP TMS S.A.
FOCL
|
+$1.03M |
| 5 |
Simon Property Group
SPG
|
+$847K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.37% |
| 2 | Healthcare | 10.03% |
| 3 | Financials | 4.46% |
| 4 | Consumer Discretionary | 3.02% |
| 5 | Real Estate | 2.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCBO
51
Docebo
DCBO
$520M
| $567K | 0.26% |
10,945
| – | – |
|
|
CDR
52
DELISTED
Cedar Realty Trust, Inc
CDR
| $492K | 0.23% |
17,805
-14,050
| -44% | -$353K |
|
|
ITI
53
DELISTED
Iteris, Inc.
ITI
| $488K | 0.23% |
+163,905
| New | +$568K |
|
|
NBSE
54
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $482K | 0.22% |
12,828
+1,365
| +12% | +$47.2K |
|
55
Cognition Therapeutics
CGTX
$89.5M
| $473K | 0.22% |
+175,366
| New | +$676K |
|
56
Ideal Power
IPWR
$67.7M
| $465K | 0.21% |
52,888
+6,613
| +14% | +$59K |
|
57
Wells Fargo
WFC
$268B
| $458K | 0.21% |
9,459
| – | – |
|
58
X4 Pharmaceuticals
XFOR
$407M
| $438K | 0.2% |
8,338
-3,012
| -27% | -$173K |
|
59
PDS Biotechnology
PDSB
$40.8M
| $436K | 0.2% |
70,378
-425
| -0.6% | -$2.64K |
|
60
Independence Realty Trust
IRT
$4.02B
| $431K | 0.2% |
+16,314
| New | +$400K |
|
|
YTEN
61
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $427K | 0.2% |
3,358
+38
| +1% | +$3.92K |
|
|
CTO
62
CTO Realty Growth
CTO
$817M
| $410K | 0.19% |
18,540
-5,250
| -22% | -$108K |
|
63
Franklin Wireless
FKWL
$26.8M
| $394K | 0.18% |
98,826
| – | – |
|
64
Abeona Therapeutics
ABEO
$389M
| $392K | 0.18% |
49,791
+4,300
| +9% | +$29.5K |
|
|
SLNO
65
DELISTED
Soleno Therapeutics
SLNO
| $377K | 0.17% |
+112,789
| New | +$584K |
|
66
Rezolute
RZLT
$489M
| $354K | 0.16% |
104,709
+43,991
| +72% | +$169K |
|
67
Vail Resorts
MTN
$5.31B
| $350K | 0.16% |
1,345
+485
| +56% | +$132K |
|
68
Cellectar Biosciences
CLRB
$20.8M
| $315K | 0.15% |
1,527
+841
| +123% | +$147K |
|
69
DexCom
DXCM
$32.7B
| $304K | 0.14% |
2,376
+496
| +26% | +$54.3K |
|
70
Blackstone Mortgage Trust
BXMT
$2.43B
| $299K | 0.14% |
9,400
+1,000
| +12% | +$31.4K |
|
|
EQC
71
DELISTED
Equity Commonwealth
EQC
| $298K | 0.14% |
10,553
-450
| -4% | -$12K |
|
72
Bridgeline Digital
BLIN
$15M
| $294K | 0.14% |
154,143
-49,882
| -24% | -$96.7K |
|
73
Kite Realty
KRG
$5.62B
| $291K | 0.13% |
12,800
-50
| -0.4% | -$1.09K |
|
|
CIO
74
DELISTED
City Office REIT
CIO
| $283K | 0.13% |
16,050
-6,700
| -29% | -$120K |
|
75
Uber
UBER
$147B
| $283K | 0.13% |
+7,943
| New | +$286K |
|
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Worth Venture Partners held 169 positions worth $217M, up 7.3% from $202M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Worth Venture Partners withdrew a net $10.7M in Q1 2022, closing 23 positions and reducing 19 holdings. Its most notable exit was Lantronix, an estimated $1.24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Worth Venture Partners opened a new position in Transphorm, Inc. Common Stock worth $4.31M.
- Worth Venture Partners's largest Q1 2022 buy was Transphorm, Inc. Common Stock: 609,170 shares worth $4.31M.
- Worth Venture Partners added most to DZS Inc. Common Stock in Q1 2022, an estimated $1.72M increase.
- Worth Venture Partners's biggest Q1 2022 reduction was EDAP TMS S.A., cutting an estimated $1.03M.
- Worth Venture Partners fully exited Lantronix in Q1 2022, selling an estimated $1.24M.
- Worth Venture Partners's ten largest holdings make up 32% of its $217M portfolio in Q1 2022.
- Worth Venture Partners opened 34 new positions and closed 23 in Q1 2022.
- Worth Venture Partners's portfolio value rose 7.3% quarter-over-quarter to $217M.
Based on Worth Venture Partners's 13F filing for Q1 2022, filed 16 May 2022.